Safety of daily Co-trimoxazole in pregnancy in an area of changing malaria epidemiology: A phase 3b randomized controlled clinical trial

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Manyando, Christine ^a,e   Njunju, Eric M ^a,e   Mwakazanga, David ^a   Chongwe, Gershom ^a   Mkandawire, Rhoda ^b   Champo, Davies ^a   Mulenga, Modest ^a   De Crop, Maaike ^c   Claeys, Yves ^c   Ravinetto, Raffaella M ^c,f   Van Overmeir, Chantal ^c   D'Alessandro, Umberto ^c,d   Van Geertruyden, Jean Pierre ^e  

^a TROPICAL DISEASES RESEARCH CENTRE   (Zambia)

^b Choma District Health Management Team ^*  (Zambia)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^e UNIVERSITY OF ANTWERP   (Belgium)

^f UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; PYRIMETHAMINE PLUS SULFADOXINE; TRIMETHOPRIM; ANTIMALARIAL AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; DELIVERY; DISEASE SEVERITY; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; FEMALE; FETUS DEATH; FEVER; FOLLOW UP; GASTROINTESTINAL DISEASE; GENERAL BODY PAIN; GESTATIONAL AGE; HEADACHE; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPOTENSION; IMMINENT ABORTION; IMPETIGO; INCIDENCE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN DEATH; OPEN STUDY; PAIN; PERINATAL MORTALITY; PHASE 3 CLINICAL TRIAL; PLACENTA MALARIA; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PROGENY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SEPTICEMIA; SPONTANEOUS ABORTION; STILLBIRTH; TENDINITIS; URINARY TRACT INFECTION; VAGINA CANDIDIASIS; WEAKNESS; ZAMBIA; ADULT; BIRTH WEIGHT; CLINICAL TRIAL; COMPLICATION; DRUG ADMINISTRATION; ENVIRONMENTAL EXPOSURE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALARIA; MALE; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY COMPLICATIONS, PARASITIC; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; ANTIMALARIALS; BIRTH WEIGHT; DRUG ADMINISTRATION SCHEDULE; FEMALE; GESTATIONAL AGE; HIV INFECTIONS; HUMANS; MALARIA; MALE; MATERNAL EXPOSURE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY COMPLICATIONS, PARASITIC; PREGNANCY OUTCOME; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; YOUNG ADULT; ZAMBIA;

EID: 84901374475     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096017     Document Type: Article

References (46)

1. WHO (2012) World Malaria Report.
2. WHO (2006) Roll Back Malaria Partnership.
3. Shulman CE, Dorman EK (2003) Reducing childhood mortality in poor countries - importance and prevention of malaria in pregnancy. Trans R Soc Trop Med Hyg 97: 30-35. (Pubitemid 36880725)
4. Whitty CJ, Edmonds S, Mutabingwa TK (2005) Malaria in pregnancy. BJOG, 112: 1189-1195. (Pubitemid 43960913)
5. WHO: Assessment of the safety of artemisinin compounds in pregnancy [http://www.who.int/entity/malaria/publications/atoz/9789241596114/en/index. html].Accessed 2014 April 15.
6. Nosten F, McGready R, Simpson JA, Thwai KL, Balkan S, et al (1999) Effects of Plasmodium vivax malaria in pregnancy. Lancet 354: 546-549. (Pubitemid 29381368)
7. Steketee R, Wirima JJ HA, Slustker L, Heymann DL, Brenman JG (1996) The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity and intrauterine growth retardation in rural malawi. Am J Trop Med Hyg 55: 33-41.
8. van Geertruyden JP, Thomas F, Erhart A, D'Alessandro U (2004) The contribution of malaria in pregnancy to perinatal mortality. Am J Trop Med Hyg 71: 35-40. 71/2-suppl/35 [pii].
9. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, et al (2007) Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 7: 93-104. S1473-3099(07)70021-X [pii]; 10.1016/S1473-3099(07)70021-X [doi].
10. Steketee R, Wirima JJ, Bloland PB, Chilima B, Mermin JH, et al (1996) Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg 55: 42-49.
11. Allen S, Van de perre P, Serufilira A, Lepage P, Carael M, et al (1991) Human Immunodeficiency virus and malaria in a representative sample of childbearing women in Kigali, Rwanda. J infect Dis 164: 67-71.
12. ter Kuile FO, Parise ME, Verhoeff FH, Udhayakumar V, Newman RD, et al (2004) The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. Am J Trop Med Hyg 71: 41-54. 71/2-suppl/41 [pii].
13. Verhoeff FH, Brabin BJ, Hart CA, Chimsuku L, Kazembe P, et al (1999) Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control. Trop Med Int Health 4: 5-12. (Pubitemid 29081212)
14. van Eijk AM, Ayisi JG, ter Kuile FO, Misore AO, Otieno JA, et al (2002) Risk factors for malaria in pregnancy in an urban and peri-urban population in western Kenya. Trans R Soc Trop Med Hyg 96: 586-592. (Pubitemid 36231474)
15. Ayisi JG, van Eijk AM, ter Kuile FO, Kolczak MS, Otieno JA, et al (2003) The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya. AIDS 17: 585-594. 10.1097/01.aids.0000042977.95433.37 [doi]. (Pubitemid 36293112)
16. Ticconi C, Mapfumo M, Dorrucci M, Naha N, Tarira E, et al (2003) Effect of maternal HIV and malaria infection on pregnancy and perinatal outcome in Zimbabwe. J Acquir Immune Defic Syndr 34: 289-294. (Pubitemid 37377362)
17. Bloland PB, Wirima JJ, Steketee RW, Chilima B, Hightower A, et al (1995) Maternal HIV infection and infant mortality in Malawi: Evidence for increased mortality due to placental malaria infection. AIDS 9: 721-726.
18. Anglaret X, Chene G, Attia A, Toure S, Lafont S, et al (1999) Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire: a randomised trial. Cotrimo-CI Study Group. Lancet 353: 1463-1468. S0140673698073991 [pii].
19. Brentlinger PE, Behrens CB, Micek MA (2006) Challenges in the concurrent management of malarria and HIV in pregnancy in subsaharan Africa. Lancet Infect Dis 6: 100-111. (Pubitemid 43138908)
20. WHO (2010) World Malaria Report. [www.who.int/entity/malaria/ publications/atoz/9789241564106/en/]. Accessed 2014 April 15.
21. WHO (2007) Assessment of the safety of artemisinin compounds in pregnancy. [http:www.who.int/malaria/publications/atoz/9789241596114/en/index. html]. Accessed 2014 April 15.
22. WHO (2010) World Malaria report: Summary. [http://www.who.int/malaria/ world-malaria-report-2010/malaria2010-summary-keypoints-en.pdf]. Accessed 2014 April 15.
23. Garner P GA (2003) Drugs for preventing malaria-related illness in pregnant women and death in the newborn. 1:CD000169.
24. Cot M, Deloron P (2003) Malaria prevention strategies. Br Med Bull 67: 137-148. (Pubitemid 38111997)
25. Peters PJ, Thigpen MC, Parise ME, Newman RD (2007) Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment. Drug Saf 30: 481-501. 3063 [pii].
26. WHO (2012) Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP). [http://www.who.int/malaria/ publications/atoz/who-iptp-sp-policy-recommendation/en/]. Accessed 2014 April 15.
27. Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, et al (1998) Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 59: 813-822. (Pubitemid 28524544)
28. Verhoeff FH, Brabin BJ, Chimsuku L, Kazembe P, Russell WB, et al (1998) An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi. Ann Trop Med Parasitol 92: 141-150. (Pubitemid 28140462)
29. Omar SA, Bakari A, Owiti A, Adagu IS, Warhurst DC (2001) Co-trimoxazole compared with sulfadoxine-pyrimethamine in the treatment of uncomplicated malaria in Kenyan children. Trans R Soc Trop Med Hyg 95: 657-660. (Pubitemid 34202259)
30. Mermin J, Lule J, Ekwaru JP, Malamba S, Downing R, et al (2004) Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 364: 1428-1434. S0140673604172255 [pii]; 10.1016/S0140-6736(04)17225-5 [doi].
31. Hauth JC, Goldenberg RL, Andrew WN, Dubard MB, Copper RL (1995) Reduced incidence of preterm delivery with metronidazole and erytromycin in women with bacterial vaginosis. N Engl J Med 333: 1732-1736. (Pubitemid 26007124)
32. Walter J, Mwiya M, Scott N, Kasonde P, Sinkala M, et al (2006) Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts. J Infect Dis 194: 1510-1518. JID36726 [pii]; 10.1086/508996 [doi].
33. Manyando C, Njunju EM, D'Alessandro U, van Geertruyden JP (2013) Safety and Efficacy of Co-Trimoxazole for Treatment and Prevention of Plasmodium falciparum Malaria: A systematic Review. PLos one 8: e56916.
34. Chizema-Kawesha E, Miller JM, Steketee RW, Mukonka V, Mukuka C, et al (2010) Scaling up malaria control in Zambia: progress and impact 2005-2008. Am J Trop Med Hyg 83: 480-488.
35. Masaninga F, Sekeseke-Chinyama M, Malambo T, Moonga H, Babaniyi O, et al (2012) Finding parasites and finding challenges: improved diagnostic access and trends in reported malaria and anti-malarial drug use in Livingstone district, Zambia. Malar J 11.
36. Dubowitz LMS, Dubowitz V, Goldberg C (1970) Clinical assessment of gestational age in the new born infant. J Pediatr 77: 1-10.
37. WHO (2006) Guidelines on Cotrimoxazole prophylaxis for HIV-related infections among children, adolescents and adults: Recommendations for a public health approach. [http://www.who.int/hiv/pub/guidelines/ctx/en/]. Accessed 2014 Apr 15.
38. Thera MA, Sehdev PS, Coulibaly D, Traore K, Garba MN, et al (2005) Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease. J Infect Dis 192: 1823-1829. JID35552 [pii]; 10.1086/498249 [doi].
39. Meshnick SR, Mwapasa V, Rogerson S (2006) Protecting pregnant women from malaria in areas of high HIv infection prevalence. J infect Dis 194: 273-275. (Pubitemid 44116967)
40. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J (2001) The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study. Reprod Toxicol 15: 637-646. S0890623801001782 [pii].
41. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA (2000) Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 343: 1608-1614. 10.1056/NEJM200011303432204 [doi]. (Pubitemid 32162984)
42. Siega-Riz AM, Savitz DA, Zeisel SH, Thorp JM, Herring A (2004) Second trimester folate status and preterm birth. Am J Obstet Gynecol 191: 1851-1857. S0002937804008609 [pii]; 10.1016/j.ajog.2004.07.076 [doi].
43. Marti-Carvajal V, Pena-Marti, Comunian-Carraso G (2004) Prematurity and maternal folate deficiency: anaemia during pregnancy study group results in Valencia, Venezuela. Arch LatinoamNutri 54: 45-49.
44. Juarez-Vazquez J, Bonizzoni E SA (2002) Iron plus folate is more effective than iron alone in the treatment of iron deficiency anaemia in pregnanct: a randomised, bouble blind clinical trial. BJOG 109: 1009-1014. (Pubitemid 35279131)
45. Manyando C, Mkandawire R, Puma L, Sinkala M, Mpabalwani E, et al. (2010) Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia. Malaria J, 9: 249.
46. Altman DG, Bland JM (1995) Absence of evidence is not evidence of absence BMJ, 311 (7003): 485.